Sahajanand Medical Technologies (SMT), one of India’s leading cardiovascular medical devices companies, has announced the appointment of Bhargav Kotadia, CEO & managing director, as the co-chair of the FICCI Medical Devices Committee for 2025–2026.
This marks the fourth consecutive year that SMT continues to hold this prestigious leadership position at the Federation of Indian Chambers of Commerce & Industry (FICCI).
FICCI, India’s apex industry chamber with a legacy back to 1927, engages with government, industry, academia and research institutions to build sectoral growth and policy frameworks. The Medical Devices Committee plays a pivotal role in shaping India’s Medtech agenda and sectoral priorities.
Accepting the appointment, Kotadia said, “I am honoured to accept the position. The medical devices industry is recognized as one of India’s most promising sectors, poised for significant growth over the coming decade, with industry estimates indicating the potential to reach around US$ 30 billion by 2030. The sector’s growth is central to PM Narendra Modi’s vision of a Viksit Bharat, as India works towards becoming a global hub for healthcare manufacturing and innovation. With FICCI’s continued leadership and strong collaboration between industry and government, we will work towards strengthening India’s MedTech ecosystem, enhancing global competitiveness, and supporting sustainable, innovation-led growth.”
SMT’s sustained leadership role within FICCI’s Medical Devices Committee underscores the company’s commitment to national and global healthcare priorities, innovation-driven manufacturing, and sectoral policy advocacy.
Over the past years, SMT has actively contributed to advancing discussions on regulatory reforms, import substitution, R&D enhancement, Free Trade Agreements and adoption of cutting-edge technologies in healthcare delivery.
